BUY 1 GET 1 50% OFF
no code needed

every product, sitewide — no code, applied automatically at checkout

side-by-side research comparison

IGF-1 LR3 vs NAD+

IGF-1 LR3 and NAD+ are both studied in longevity research, but they are different classes of compound with different reported research applications.

✓ both US-made · third-party tested · batch COA on every order

Last updated August 25, 2026

How do IGF-1 LR3 and NAD+ differ?

IGF-1 LR3 (Recombinant IGF-1 analog polypeptide) is catalogued under longevity & cellular research; NAD+ (Nicotinamide adenine dinucleotide · cellular-metabolism research) is catalogued under longevity & cellular research. Verve lists 5 reported research applications for IGF-1 LR3 and 5 for NAD+. Both are made in the United States, screened by HPLC to a 99%+ purity standard, and shipped with a batch-level certificate of analysis.

IGF-1 LR3 compared with NAD+ across compound class, research area, supply format, purity standard, documentation, catalog price and stock.
fieldIGF-1 LR3NAD+
compound classRecombinant IGF-1 analog polypeptideNicotinamide adenine dinucleotide · cellular-metabolism research
research arealongevity & cellularlongevity & cellular
reported research applications5 listed5 listed
supplied assingle compoundsingle compound
catalog sizes1mg · 2x 1mg1000mg
purity standard99%+ by HPLC99%+ by HPLC
manufacturedUnited StatesUnited States
batch COApublished per lotpublished per lot
endotoxin-tested optionavailableavailable
co-formulated together innot co-formulatednot co-formulated
price from$93.49$78.99
availabilityout of stockin stock

Prices and stock read live from the catalog. Both compounds are supplied strictly as reference materials for in-vitro laboratory research.

What is IGF-1 LR3 and what is NAD+?

IGF-1 LR3 is classified as Recombinant IGF-1 analog polypeptide; NAD+ as Nicotinamide adenine dinucleotide · cellular-metabolism research. Both profiles below cover scientific identity only — what the molecule is and which laboratory models it appears in. Verve supplies both strictly as in-vitro reference materials, and neither profile describes human or veterinary use.

IGF-1 LR3

Recombinant IGF-1 analog polypeptide

IGF-1 LR3 is Long R3 insulin-like growth factor 1, a recombinant analog of human IGF-1 carrying an arginine substitution at position 3 and a 13-residue N-terminal extension. Those two modifications are what define it: they substantially reduce its affinity for the insulin-like growth factor binding proteins (IGFBPs) that sequester native IGF-1 in culture systems.

full IGF-1 LR3 profile →

NAD+

Nicotinamide adenine dinucleotide · cellular-metabolism research

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every living cell and central to redox reactions and cellular energy metabolism. Verve's NAD+ is a high-purity research preparation supplied for the laboratory study of cellular energetics and redox biology.

full NAD+ profile →

Which research models is each compound studied in?

IGF-1 LR3 and NAD+ both sit inside longevity & cellular research, so their listed models share framing while differing in specifics. The table lists 5 reported research applications for IGF-1 LR3 and 5 for NAD+. Rows are per compound, not equivalences.

Reported research applications listed for IGF-1 LR3 and for NAD+. Entries are listed per compound; a shared row is not a claim that the two applications are equivalent.
IGF-1 LR3 — reported research applicationsNAD+ — reported research applications
IGF-1 receptor binding and signal-transduction researchCellular energy-metabolism research
PI3K/Akt and MAPK pathway research in cellular modelsSirtuin and PARP enzyme research
Cell-culture media supplementation for proliferation researchMitochondrial-function research models
IGFBP interaction and free-ligand availability studiesRedox-biology (NAD+/NADH ratio) research
Comparative analog research against native IGF-1Longevity and cellular-aging research models

Research contexts only. Both compounds are supplied for laboratory research use only, and no entry above describes an effect in humans or animals.

What sizes and prices does verve list for IGF-1 LR3 and NAD+?

IGF-1 LR3 is listed from $93.49 and NAD+ from $78.99. The table below is every catalog size verve currently lists for the two compounds, at single-vial prices before the automatic multi-compound discount. Sizes describe the vial format supplied to the laboratory, nothing more.

Catalog sizes, single-vial prices and stock status for IGF-1 LR3 and NAD+.
compoundsize listedpriceavailability
IGF-1 LR31mg$93.49out of stock
IGF-1 LR32x 1mg$171.49out of stock
NAD+1000mg$78.99in stock
IGF-1 LR3out of stock
NAD+ Nasal Sprayfrom $78.99

Any 2 different compounds take 20% off, any 3 take 30% — applied automatically in the cart, no code. Orders placed Monday–Friday ship by 2pm CT, free over $100.

shop the compounds →

Frequently asked questions about IGF-1 LR3 and NAD+

What is IGF-1 LR3?

IGF-1 LR3 is Long R3 insulin-like growth factor 1, a recombinant analog of human IGF-1 with an arginine substitution at position 3 and an N-terminal extension. Verve supplies it as a research compound for laboratory use only, not for human or veterinary use.

How does IGF-1 LR3 differ from native IGF-1?

Its structural modifications reduce affinity for IGF binding proteins, so more of the ligand remains unbound in culture systems. Researchers use that property to control free-ligand availability in in-vitro models.

What is NAD+?

NAD+ is nicotinamide adenine dinucleotide, a coenzyme central to redox reactions and energy metabolism in cells. Verve supplies a high-purity research preparation for laboratory use only.

What is NAD+ studied for in research?

It is used in research on cellular energy metabolism, sirtuin and PARP enzyme activity, mitochondrial function, and DNA-repair pathways. It is not for human or veterinary use.

related comparisons

verve products are sold for laboratory research and development purposes only and are not intended for human or veterinary use of any kind. statements on this site have not been evaluated by the FDA.